BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33151381)

  • 1. Long-term renal outcomes after elective percutaneous coronary intervention in patients with advanced renal dysfunction.
    Tashiro H; Tanaka A; Ishii H; Takagi K; Uemura Y; Inoue Y; Umemoto N; Negishi Y; Shibata N; Yoshioka N; Shimizu K; Morishima I; Watarai M; Asano H; Murohara T;
    Heart Vessels; 2021 Apr; 36(4):452-460. PubMed ID: 33151381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trajectory of renal function change and kidney injury after percutaneous coronary intervention in patients with stable coronary artery disease.
    Deguchi Y; Saito Y; Nakao M; Shiraishi H; Sakamoto N; Kobayashi S; Kobayashi Y
    Heart Vessels; 2021 Mar; 36(3):315-320. PubMed ID: 32930865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimal strategy for coronary revascularization in patients with severe renal dysfunction.
    Komiya T; Ueno G; Kadota K; Mitsudo K; Okabayashi H; Nishiwaki N; Hanyu M; Kimura T; Tanaka S; Marui A; Sakata R;
    Eur J Cardiothorac Surg; 2015 Aug; 48(2):293-300. PubMed ID: 25416698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between deteriorated renal function and long-term clinical outcomes after percutaneous coronary intervention.
    Ogita M; Sakakura K; Nakamura T; Funayama H; Wada H; Naito R; Sugawara Y; Kubo N; Ako J; Momomura S
    Heart Vessels; 2012 Sep; 27(5):460-7. PubMed ID: 21822708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-Induced Nephropathy and Long-Term Clinical Outcomes Following Percutaneous Coronary Intervention in Patients With Advanced Renal Dysfunction (Estimated Glomerular Filtration Rate <30 ml/min/1.73 m
    Negishi Y; Tanaka A; Ishii H; Takagi K; Inoue Y; Uemura Y; Umemoto N; Yoshioka N; Morishima I; Asano H; Watarai M; Shibata N; Suzuki S; Murohara T
    Am J Cardiol; 2019 Feb; 123(3):361-367. PubMed ID: 30477803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Renal Dysfunction.
    Malik AO; Spertus JA; Grantham JA; Peri-Okonny P; Gosch K; Sapontis J; Moses J; Lombardi W; Karmpaliotis D; Nicholson WJ; Al Badarin F; Salisbury AC
    Am J Cardiol; 2020 Apr; 125(7):1046-1053. PubMed ID: 31955832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome.
    Nemoto N; Iwasaki M; Nakanishi M; Araki T; Utsunomiya M; Hori M; Ikeda N; Makino K; Itaya H; Iijima R; Hara H; Takagi T; Joki N; Sugi K; Nakamura M
    Am J Cardiol; 2014 May; 113(10):1647-51. PubMed ID: 24656479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.
    Stähli BE; Gebhard C; Gick M; Ferenc M; Mashayekhi K; Buettner HJ; Neumann FJ; Toma A
    Clin Res Cardiol; 2018 Mar; 107(3):259-267. PubMed ID: 29134346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Renal Function After Percutaneous Coronary Intervention in Non-Dialysis Patients With Acute Coronary Syndrome and Advanced Renal Dysfunction.
    Uemura Y; Ishikawa S; Takemoto K; Negishi Y; Tanaka A; Takagi K; Yoshioka N; Tashiro H; Umemoto N; Inoue Y; Morishima I; Shimizu K; Shibata N; Asano H; Ishii H; Watarai M; Murohara T;
    Cardiovasc Revasc Med; 2021 Mar; 24():26-30. PubMed ID: 32952075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study.
    Vuurmans T; Er L; Sirker A; Djurdjev O; Simkus G; Levin A
    Coron Artery Dis; 2018 Jan; 29(1):8-16. PubMed ID: 28938241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra-Low Contrast Percutaneous Coronary Intervention to Minimize the Risk for Contrast-Induced Acute Kidney Injury in Patients With Severe Chronic Kidney Disease.
    Azzalini L; Laricchia A; Regazzoli D; Mitomo S; Hachinohe D; Bellini B; Demir OM; Poletti E; Maccagni D; Colombo A
    J Invasive Cardiol; 2019 Jun; 31(6):176-182. PubMed ID: 30865912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Kidney Disease in the Second-Generation Drug-Eluting Stent Era: Pooled Analysis of the Korean Multicenter Drug-Eluting Stent Registry.
    Lee JM; Kang J; Lee E; Hwang D; Rhee TM; Park J; Kim HL; Lee SE; Han JK; Yang HM; Park KW; Na SH; Kang HJ; Koo BK; Kim HS
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2097-2109. PubMed ID: 27692820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Versus Without Chronic Kidney Disease.
    Yamamoto K; Natsuaki M; Morimoto T; Shiomi H; Takeji Y; Kadota K; Imada K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Kato E; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T
    Am J Cardiol; 2021 Apr; 145():37-46. PubMed ID: 33454346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of chronic kidney disease on long-term outcomes following semi-urgent and elective percutaneous coronary intervention.
    Soh RY; Sia CH; Lau RH; Ho PY; Timothy NY; Ho JS; Kaur H; Sim HW; Yeo TC; Tan HC; Chan MY; Loh JP
    Coron Artery Dis; 2021 Sep; 32(6):517-525. PubMed ID: 33229937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
    Yamamoto K; Shiomi H; Morimoto T; Natsuaki M; Takeji Y; Watanabe H; Yoshikawa Y; Matsumura-Nakano Y; Shizuta S; Tanabe K; Ando K; Kadota K; Morino Y; Kozuma K; Nakagawa Y; Kimura T
    Am J Cardiol; 2020 Feb; 125(3):399-408. PubMed ID: 31771755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.